1261225-49-3 Usage
General Description
The chemical "[3-(1R,3S)-benzyloxycarbonylaminocyclohexyl]-1-carbamic acid tertbutyl ester" is a compound with molecular formula C21H32N2O4. It is a carbamate derivative, containing a cyclohexyl group, a benzyloxycarbonyl group, and a tertbutyl ester group. [3-(1R,3S)-benzyloxycarbonylaminocyclohexyl]-1-carbamic acid tertbutyl ester may have biological and pharmaceutical applications due to its potential as an inhibitor or modulator in enzymatic reactions or biochemical processes. Its specific properties and potential uses would depend on further studies and investigations.
Check Digit Verification of cas no
The CAS Registry Mumber 1261225-49-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,2,2 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1261225-49:
(9*1)+(8*2)+(7*6)+(6*1)+(5*2)+(4*2)+(3*5)+(2*4)+(1*9)=123
123 % 10 = 3
So 1261225-49-3 is a valid CAS Registry Number.
1261225-49-3Relevant articles and documents
BCAT MODULATION
-
Paragraph 0283, (2021/01/29)
This disclosure relates to, in part, the treatment of an organic acidemia in a subject in need thereof via administration of a therapeutically effective amount of compounds that inhibit BCAT2. The disclosure also relates to, in part, methods for identifying a candidate compound for treatment of organic acidemias.
Heteroaromatic nitrile compound and application thereof
-
Paragraph 0458-0460, (2020/07/21)
The invention discloses a heteroaromatic nitrile compound and application thereof. The invention provides a heteroaromatic nitrile compound shown as formula I or a pharmaceutically acceptable salt thereof. The compound has a good inhibition effect on CDK7.
HETEROCYCLIC INDOLES FOR USE IN INFLUENZA VIRUS INFECTION
-
, (2017/06/30)
The current invention relates to a compound of formula (I) which can be used for the treatment of, or against viral influenza infections.
